Wu, L., Chen, Z., Yu, Q., Fang, J., Chen, Y., Chen, Y., . . . Peng, Z. (2023). NAD (P)H Quinone Dehydrogenase 1‑Targeting Triptolide Analogue Causes Tumor Regression and Sensitizes Cisplatin-Resistant Lung Cancer to Chemotherapy. ACS Pharmacology & Translational Science, 6(10), 1508-1517. https://doi.org/10.1021/acsptsci.3c00144
Chicago-referens (17:e uppl.)Wu, Liuying, et al. "NAD (P)H Quinone Dehydrogenase 1‑Targeting Triptolide Analogue Causes Tumor Regression and Sensitizes Cisplatin-Resistant Lung Cancer to Chemotherapy." ACS Pharmacology & Translational Science 6, no. 10 (2023): 1508-1517. https://doi.org/10.1021/acsptsci.3c00144.
MLA-referens (9:e uppl.)Wu, Liuying, et al. "NAD (P)H Quinone Dehydrogenase 1‑Targeting Triptolide Analogue Causes Tumor Regression and Sensitizes Cisplatin-Resistant Lung Cancer to Chemotherapy." ACS Pharmacology & Translational Science, vol. 6, no. 10, 2023, pp. 1508-1517, https://doi.org/10.1021/acsptsci.3c00144.
